0
Article   |    
FURTHER EXPERIENCES OF THE USE OF MALONONITRILE IN THE TREATMENT OF MENTAL ILLNESSES
HANS HARTELIUS
Am J Psychiatry 1950;107:95-101.
View Article Information
The Psychiatric Clinic of the Caroline Hospital (Head: Professor T. Sjögren) and the Medical Nobel Institute (Professor H. Hydén), Stockholm.
text A A A
PDF of the full text article.
Abstract
1. The present paper offers some comments on the preliminary report by MacKinnion, Hoch, Cammer, and Waelsch on the treatment of mental illnesses with malononitrile. The forementioned authors reported 9 cases and stated that they obtained negative results. Their negative results are correlated by the writer to the short duration of the individual treatments.To this extent, the results of MacKinnon et al. confirm the experience of the writer (Hydén and Hartelius 1948). No therapeutic effects have been observed to follow an m-treatment with a duration of only 15 minutes. In order to obtain results, emphasis is placed here—as in the earlier report (1948)—on the importance of a sufficiently long duration of the individual treatment.2. The writer also reports on a more recent series of 40 patients with recorded katamneses.3. Each patient was given an average of 1,250 mg. The average individual dose was 2.4 mg/kg body weight. The average dura-of the m-stage was 48 minutes. The average number of treatments in a course was 8.4. Table 1 shows the distribution of the cases according to the diagnoses. Endogenous depressions predominate.5. The mental effect is in the nature of a stimulation that becomes evident within 24-48 hours of each treatment.6. The results are collocated in Table 2. They are markedly positive in 23 cases, relatively positive in 9, and negative in 8. The results are lasting in 22 cases and transient in 10.7. The relation between malononitrile treatment and ECT and other forms of therapy is discussed. Twenty-six patients received ECT before malononitrile treatment, with varying results. Contraindications to ECT were present in 23 cases.8. The clinical value of the method is due mainly to the positive results, its freedomfrom risks, and the fact that it is less limited than ECT by contraindications.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Books
    The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 27.  >
    Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 52.  >
    The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 44.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 27.  >
    Topic Collections
    Psychiatric News
    APA Guidelines